CD79A and Crohn disease: To our knowledge, this is the first study to evaluate the salivary levels of specific IgA and IgG antibodies against P. gingivalis, T. forsythia, A. actinomycetemcomitans, and P. intermedia in patients with Crohn’s diseases.